Virtus ETF Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,171
Closed -$712K 531
2019
Q3
$712K Sell
7,171
-1,217
-15% -$116K 0.14% 161
2019
Q2
$775K Buy
+8,388
New +$797K 0.16% 188
2019
Q1
Sell
-8,835
Closed -$566K 310
2018
Q4
$566K Sell
8,835
-997
-10% -$73.6K 0.1% 62
2018
Q3
$880K Buy
9,832
+673
+7% +$59.5K 0.09% 59
2018
Q2
$727K Buy
9,159
+845
+10% +$70.2K 0.64% 87
2018
Q1
$742K Sell
8,314
-491
-6% -$47.1K 0.64% 88
2017
Q4
$919K Buy
8,805
+254
+3% +$28.7K 1.15% 40
2017
Q3
$1.25M Hold
8,551
0.17% 50
2017
Q2
$1.11M Sell
8,551
-389
-4% -$47.7K 0.17% 46
2017
Q1
$1.11M Buy
8,940
+859
+11% +$103K 0.2% 59
2016
Q4
$935K Buy
8,081
+1,919
+31% +$214K 0.28% 62
2016
Q3
$644K Buy
6,162
+776
+14% +$84K 0.31% 59
2016
Q2
$531K Buy
5,386
+502
+10% +$51.9K 0.39% 47
2016
Q1
$489K Hold
4,884
0.67% 38
2015
Q4
$585K Buy
+4,884
New +$565K 1.61% 23

Other funds holding CELG

Virtus ETF Advisers's CELG Position: Q4 2019 in Review

Virtus ETF Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,171 shares — an estimated $712K sold.

Virtus ETF Advisers first reported a position in CELG in Q4 2015 and held it in 15 quarters. The position peaked at $1.25M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Virtus ETF Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Virtus ETF Advisers sold 7,171 Celgene Corp shares in Q4 2019, an estimated $712K.
  • Virtus ETF Advisers first reported a position in Celgene Corp in Q4 2015 and held it in 15 quarters.
  • Virtus ETF Advisers's Celgene Corp position peaked at $1.25M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.